組織因子経路阻害剤の欠乏は,マウスの動脈硬化症と血栓形成を促進する
R J Westrick1, P F Bodary, Z Xu
1Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
Circulation
|June 27, 2001
まとめ
組織因子経路阻害剤 (TFPI) の欠乏は動脈硬化症を悪化させ,マウスの血栓形成を促進する. TFPIのレベルが低下すると,プラークの負荷が増加し,血栓形成が加速され,TFPIの保護的役割が強調されます.
科学分野:
- 心血管生物学 心血管生物学
- ヘモスタシスとトランボシス
- 動脈硬化症の研究研究
背景:
- 組織因子 (TF) は,動脈硬化性プラークの破裂後に血液凝固を開始します.
- 組織因子経路阻害剤 (TFPI) は,TFの活性に敵対し,潜在的に血栓形成を緩和します.
- 動脈硬化と血栓性合併症の発達におけるTFPIの役割は,まだ完全に解明されていない.
研究 の 目的:
- ヘテロジゴス型TFPI欠乏症が動脈硬化症の進行に及ぼす影響を調査する.
- 動脈硬化症のマウスモデルにおけるTFPI欠乏が血栓形成に及ぼす影響を評価する.
主な方法:
- TFPI ((+/-) / apoE ((-/-)) のマウスの生成は,TFPIヘテロジゴスおよびapoEホモジゴス欠乏マウスを交配することによって行われます.
- 血管樹全体における動脈硬化負荷の包括的な分析.
- 光化学的頸動脈損傷後のプラークTF活動と閉塞性血栓形成までの時間の評価.
主要な成果:
- TFPI欠乏症は,大動脈と常 iliac 動脈の動脈硬化負荷を大幅に増加させました.
- TFPI欠乏したマウスの動脈硬化性プラーク内で,上昇したTF活動が観察されました.
- TFPI欠乏症は,大動脈損傷後の閉塞性血栓形成までの時間を著しく短縮しました.
結論:
- TFPIは,動脈硬化症の発症から保護します.
- TFPIは,動脈硬化症の文脈における血栓形成の重要な調節剤である.
関連する概念動画
02:16Transcription Factors
82.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
02:40The Eukaryotic Promoter Region
18.7K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
01:52Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
01:30Atherosclerosis I: Introduction
970
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
970
01:26Atherosclerosis III: Management
337
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
337
01:30Venous Thrombosis I: Introduction
410
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
410